SDBJ: Artiva Bio Soaring on Focus Shift from Oncology to Autoimmune Disease Artiva Biotherapeutics was featured in the San Diego Business Journal highlighting the Company’s strategic transition into autoimmune disease and the FDA Fast Track Designation for AlloNK® in rheumatoid arthritis. The story outlines how AlloNK is designed for outpatient use and underscores the significant…
